Physical Compatibility of Calcium Acetate and Potassium Phosphates in Parenteral Nutrition Solutions Containing Aminosyn II
Author(s): Zhang Yanping, Xu Quanyun, Trissel Lawrence A, Baker Mary B
Issue: Sep/Oct 1999 - Natural Hormone Replacement Therapy
View All Articles in Issue
Page(s): 415-420
Download in electronic PDF format for $75
Abstract: Numerous factors have been identified that influence the
amount of calcium and phosphates that can remain in solution
or will precipitate from parenteral nutrition solutions.
Two of the most important such factors are the specific formulation
of the amino acid source and the salt form of the
calcium source. The purpose of this study was to evaluate
the physical compatibility of calcium (as acetate) and potassium
phosphates in Aminosyn® II-based parenteral nutrition
solutions.
Five representative core parenteral nutrition formulations
containing Aminosyn II 2% to 5% were evaluated. Varying
amounts of calcium acetate and potassium phosphates were
added to samples of the core formulations to identify the concentrations
at which precipitation just began to occur. A total
of five series of concentrations was tested with maxima of calcium
40 mEq/L and phosphates 40 mM/L. The samples were
evaluated by visual observation with the unaided eye and by
use of a Tyndall beam to accentuate the visibility of small particles
and low-level turbidity. For samples not exhibiting visible
particles or haze, the turbidity and particle content were
measured electronically. Evaluations were performed initially
during the first 15 minutes after mixing and after 48 hours
of storage at 23° and 37°C.
The precipitation potential of calcium and phosphates in the
five representative parenteral nutrition solutions containing
Aminosyn II at a variety of concentrations has been evaluated
over a broad range of concentrations. The results are presented
in tabular form and were used to determine the boundary between
compatibility and incompatibility in each of the five
core parenteral nutrition formulations. The boundary lines
or compatibility curves were constructed for each of the formulations
and are presented graphically.
Related Keywords:
amino acids, Aminosyn II, calcium acetate, compatibility, parenteral nutrition, phosphates, precipitate
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Physical Compatibility of Calcium Acetate and Potassium Phosphates in Parenteral Nutrition Solutions Containing Aminosyn II
Zhang Yanping, Xu Quanyun, Trissel Lawrence A, Baker Mary B
|
Sep/Oct 1999
Pg. 415-420
|
Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration
Chan Pak, Heatherly Kathy, Kupiec Thomas C, Trissel Lawrence A
|
May/Jun 2008
Pg. 276-278
|
Use of Cysteine Hydrochloride Injection to Increase the Solubility of Calcium and Phosphates in FreAmine III-Containing Parenteral Nutrition Solutions
Trissel Lawrence A, Xu Quanyun A, Zhang Yanping, Walter William V
|
Jan/Feb 2003
Pg. 71-77
|
Adult Peripheral Parenteral Nutrition Solution with 4.23% Amino Acids
Allen Loyd V Jr
|
Sep/Oct 1998
Pg. 366
|
Adult Peripheral Parenteral Nutrition Solution with 2.5% Amino Acids
Allen Loyd V Jr
|
Sep/Oct 1998
Pg. 367
|
Chemical and Physical Compatibility of an Intravenous Solution of Epinephrine with Calcium Chloride
Weeks Phillip A, Teng Yang, Wu Lei, Sun Mary, Yang Zhen, Chow Diana S-L
|
Mar/Apr 2014
Pg. 152-158
|
Calcium Acetate 667-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 229
|
Total Parenteral Nutrition for Animals
Sammarco Domenic A
|
Sep/Oct 2002
Pg. 328-330
|
Capsule and Tablet Diluents, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 2000
Pg. 306-310
|
Compatibility of Parenteral Furosemide with Seventeen Secondary Drugs Used in Standard Concentrations
Jasti Bhaskara R, Saraf Poonam
|
May/Jun 2011
Pg. 259-261
|
Intravenous Physical Compatibility of Heparin Sodium and Furosemide
Maktabi Briana, Howard Mitchell S, Baki Gabriella, Churchwell Mariann D
|
Nov/Dec 2022
Pg. 522-526
|
Compatibility and Stability of Potassium Chloride and Magnesium Sulfate in 0.9% Sodium Chloride Injection and 5% Dextrose Injection Solutions
Quay Irene, Tan Edward
|
Jul/Aug 2001
Pg. 323-324
|
A Review of Parenteral Admixtures Requiring Select Containers and Administration Sets
Rice Stephen P
|
Mar/Apr 2002
Pg. 120-122
|
Pediatric Central Parenteral Nutrition Solution
Allen Loyd V Jr
|
Sep/Oct 1998
Pg. 368
|
Pediatric Central Parenteral Nutrition Solution with Heparin
Allen Loyd V Jr
|
Sep/Oct 1998
Pg. 369
|
Pediatric Peripheral Parenteral Nutrition Solution
Allen Loyd V Jr
|
Sep/Oct 1998
Pg. 370
|
Total Parenteral Nutrition Solution
Allen Loyd V Jr
|
Nov/Dec 2001
Pg. 458
|
Physicochemical Stability and Compatibility of Revefenacin (LAMA) and Formoterol Fumarate (LABA) Inhalation Solution Admixture
Ngim Kenley, Patel Jalpa
|
May/Jun 2020
Pg. 242-245
|
Physical Compatibility of Medications Used in Critically Ill Patients with Balanced Fluid Solutions
Wilder Alyson G, Foushee Jaime A, Fox Laura M, Navalle Jordan, Wright Adrienne M, Greer Megan A
|
May/Jun 2020
Pg. 238-241
|
Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration
Lu Juan, Liu Qiang, Kupiec Thomas C, Vail Herbert, Lynch Leslie R, Fam David S, Vu Nicole T
|
Jan/Feb 2021
Pg. 52-61
|
Return to Top |